• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Rogers Corporation

Rogers Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Bristol-Myers, Five Prime to Collaborate on Immunotherapy

    Bristol-Myers, Five Prime to Collaborate on Immunotherapy

  2. Roche Gets U.S. Approval for Avastin Treatment of Ovarian Cancer

    Roche Gets U.S. Approval for Avastin Treatment of Ovarian Cancer

  3. FDA Approves Genentech’s Avastin (bevacizumab) Plus Chemotherapy to Treat Women with Platinum-Resistant Recurrent Ovarian Cancer

    FDA Approves Genentech’s Avastin (bevacizumab) Plus Chemotherapy to Treat Women with Platinum-Resistant Recurrent Ovarian Cancer

  4. Wide-Moat Funds That Fly Under the Radar

    These quality funds with smaller asset bases have portfolios built around solid companies.

  5. Funds Betting on Big Pharma

    Large drugmakers are out of favor, but some good funds are banking on a rebound.

  6. Dodge & Cox: Pharma Stocks Showing Value

    As incomes rise, emerging-markets consumers can afford more and better medications driving attractive growth in the pharmaceuticals sector, say the managers of Dodge & Cox International Stock.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.